Marie-Paule Kieny, Assistant Director General of the World Health Organization,WHO, informs the media following a panel of medical analysts to explore the ethics of experimental treatment in the Ebola outbreak, at the headquarters of the WHO in Geneva, Switzerland, Tuesday, Aug. 12, 2014. (AP Photo/Keystone, Salvatore Di Nolfi)
Marie-Paule Kieny, Assistant Director General of the World Health Organization,WHO, informs the media following a panel of medical ethicists to explore experimental treatment in the Ebola outbreak, at the headquarters of the WHO in Geneva, Switzerland, Tuesday, Aug. 12, 2014. (AP Photo/Keystone, Salvatore Di Nolfi)
Marie-Paule Kieny, Assistant Director General of the World Health Organization,WHO, informs the media following a panel of medical ethicists to explore experimental treatment in the Ebola outbreak, at the headquarters of the WHO in Geneva, Switzerland, Tuesday, Aug. 12, 2014. (AP Photo/Keystone, Salvatore Di Nolfi)
An experimental Ebola drug has been used to treat two American aid workers and a Spanish missionary priest. Could Liberian doctors be next?
The Liberian government said Monday that it will receive doses of the drug to treat two doctors in the country. They would be the first Africans to receive it.
The manufacturer, Mapp Biopharmaceutical Inc., said in a statement posted Monday afternoon on its website that the supply of the drug is now exhausted.
The announcement came as the World Health Organization considered the ethics of experimental treatment, addressing questions about who should get access to an experimental drug in an emergency […]
Read Full Story
Date: August 12, 2014
Source: Associated Press – Lauran Neergaard, AP Medical Writer
Suscríbete a nuestro blog en el menú lateral derecho para recibir nuestras publicaciones diarias directamente en tu correo electrónico.
Suscríbase a nuestro boletín informativo para recibir un correo mensual con las noticias más relevantes sobre la industria y la empresa.